<a href=«https://economictimes.indiatimes.com/divi» s-laboratories-ltd. data-ga-onclick=«Inarticle articleshow link click#Markets#href» target="_blank">Divi's Laboratories Ltd. traded 0.39 per cent down in Tuesday's trade at 01:39PM (IST). Around 8,068 shares changed hands on the counter.
The stock opened at Rs 4891.5 and touched an intraday high and low of Rs 4900.0 and Rs 4808.15, respectively, in the session so far. Shares of the company of <a href=«https://economictimes.indiatimes.com/divi» s-laboratories-ltd. data-ga-onclick=«Inarticle articleshow link click#Markets#href» target="_blank">Divi's Laboratories Ltd. quoted a 52-week high of Rs 5024.5 and a 52-week low of Rs 3300.0.
As per BSE, the total market cap of the Divi's Laboratories Ltd. stood at Rs 129520.79 crore at the time of writing this report.
Key Financials The company reported consolidated net sales of Rs 2197.0 crore for the quarter ended 30-Jun-2024, down 7.77 per cent from previous quarter's Rs 2382.0 crore and down 18.18 per cent from the year-ago quarter's Rs 1859.0 crore.
The net profit for latest quarter stood at Rs 430.0 crore, up 20.79 per cent from the same quarter a year ago.
Shareholding pattern As of 30-Jun-2024, domestic institutional investors held 13.1 per cent stake in the firm, while foreign institutional investors held 16.16 per cent and the promoters 51.9 per cent.
Valuation ratio According to BSE data, the stock traded at a P/E multiple of 77.37 and a price-to-book ratio of 6.71. A higher P/E ratio shows investors are